- Fee assured
- Verified this account
This healthcare professional is currently treating patients. Please speak to them to find out more about their availability.
Last updated: 12 Nov 2020
Michael Loebinger is a Consultant Respiratory Physician at the Royal Brompton Hospital and Professor of Practice (Respiratory Medicine) at Imperial College, London. Professor Loebinger undertook his preclinical studies at Cambridge University gaining a First Class Honours in Medical Sciences followed by study at Oxford University for his clinical studies. He was then awarded a Medical Research Council Clinical Research Training Fellowship for studies into the use of adult stem cells in lung disease. This resulted in research published in his PhD, which he was awarded by University College London.
His clinical interests cover all respiratory medicine, however he has particular interest and expertise in respiratory infection. His clinical expertise has led to multiple invitations to give lectures on these conditions nationally and internationally and his central involvement in shaping national services and guidelines. Professor Loebinger co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) and is presently secretary of the European Respiratory Society respiratory infection group. He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with Industry and is global, national and site principal investigator of multicentre international clinical trials. He has won young investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation and was awarded the European Respiratory Society research award for innovation in non-tuberculous mycobacteria in 2018. His research publications are listed on https://www.imperial.ac.uk/people/m.loebinger/publications.html
Areas of interest
Respiratory disorders; Bronchiectasis; Tuberculosis; Pulmonary infection; cough; shortness of breath; COPD; asthma; cystic fibrosis
Current NHS consultant posts held
Consultant Physician, Royal Brompton Hospital
Consultant Physician, Chelsea and Westminster Hospital (Thursday)
Professor Loebinger's research focuses on chronic lung infections, in particular bronchiectasis and pseudomonas and non-tuberculosis mycobacterial infections. He is presently investigating susceptibility to infection, in addition to the development of biomarkers to assist in management. He is principal investigator of drug studies and a founding member of national and international clinical networks of patients which will help with patient management as well as future research and clinical trials.
Professor Loebinger is a keen footballer and represented both Cambridge and Oxford University 1st XI teams in fixtures which have included English Premier League reserve teams. He continues to play regularly.
Professor Loebinger has won investigator of the year awards from the Royal Society of Medicine, European Respiratory Society, British Thoracic Society and British Association of Lung Research. He has also received awards from the American Thoracic Society, Medical Research Society and British Lung Foundation and was awarded the European Respiratory Society research award in 2018. At University he received multiple rewards including being ranked first for medicine at Cambridge University.
Multiple publications on http://www1.imperial.ac.uk/medicine/people/m.loebinger/
Reference number 4641410
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.